Pacira BioSciences, Inc. PCRX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s enterprise value?
- Pacira BioSciences, Inc. (PCRX) reported enterprise value of $1.18B in Q1 2026.
- How has Pacira BioSciences, Inc.'s enterprise value changed year-over-year?
- Pacira BioSciences, Inc.'s enterprise value decreased by 3.4% year-over-year, from $1.22B to $1.18B.
- What is the long-term trend for Pacira BioSciences, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s enterprise value has grown at a -13.2% compound annual growth rate (CAGR), from $2.79B to $1.37B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.